TP53 and cancer: Since p53 hot-spot mutants usually exert a dominant-negative effect by interfering with the DNA binding activity of WTp53, and the canonical p53 responsive elements were only found in the murine Cpt1C promoter but not in human’s (35), it is possible that Mutp53 activates CPT1C expression through an indirect mechanism in human cancer cells.